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Diagnosis of Childhood Leprosy – Changing Trends
Leprosy, a chronic infectious disease caused by mycobacterium leprae, mainly 
involves the skin, respiratory mucosa and the peripheral nervous system. Leprosy 
continues to remain a public health problem. In 2011, the global new case detection was 
219075 and in India it was 127295. Thus, India accounts for > 58% of total cases of 
leprosy worldwide. Pediatric leprosy accounts for around 10% of the total disease 
burden. 
The main source of transmission of leprosy is from the untreated lepromatous patients 
and the most common route is through the nasal secretions. From the nasal mucosa, the 
bacteria spreads by hematogenous route to skin and the peripheral nerves. The disease 
has a long incubation period of 3-5 yrs (can be upto 20 yrs).
After infection, the child first develops indeterminate leprosy which can either get 
cured spontaneously or on treatment or it can progress to one of the several clinical 
forms (tuberculoid, borderline or lepromatous).  The clinical spectrum varies from 
tuberculoid, where there are a few, large, anesthetic skin patches with thickened 
peripheral nerves and no detectable bacilli to lepromatous type where there are 
multiple, small skin lesions with intact sensation and high bacillary load. In our study 
spanning over 20 years, we have observed no significant change in the clinical profile. 
Early diagnosis of leprosy requires a high index of suspicion on the part of the clinician. 
It is based on detection of 2 of the following features, namely, characteristic skin lesion, 
loss of sensation and thickened peripheral nerves or the detection of AFB in skin or 
nasal smear. 
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We conducted a number of studies, evaluating various newer techniques for early 
detection of the disease. In one study, we found the FLA-ABS and Lepromin tests, to be 
of immense value for identification of "at risk" population in the community and for 
detecting subclinical infection. We also studied antibody response against 35k Da 
antigen by SACT and found that nearly 50% smear negative, 42% lepromin +ve and 
70% lepromin -ve cases showed positive antibody response with no false positive 
response. 
Gene probes developed at our institute were tried on 100 patients.  AII smear  +ve 
cases, lepromin +ve cases and majority of smear- ve cases were detected by this 
method.   9 cases (4 indeterminate & 5 nonspecific) with inconclusive histopathology 
were also detected. 
In another study on 22 children, in-situ hybridization technique helped in diagnosing 
the children with negative skin smear and non specific histopathology. It also permitted 
the concomitant study of tissue pathology. 
Again, in our pioneer study, evaluation of the in-situ PCR technique revealed that 
histopathology detected 45% of total cases, in-situ PCR detected as much as 60% of the 
total cases. Thus, In-situ PCR offered excellent structural correlation permitting 
concomitant study of tissue pathology. As contamination by foreign DNA/RNA does 
not exist, it is a valuable tool for diagnosis of childhood leprosy. 
RLEP based PCR is yet another useful tool to detect cases where skin smears are -ve 
and skin biopsy is not feasible. In our study involving 73 patients, Z-N staining for AFB 
was positive in 17/73 (23.28%) cases and RLEP PCR in 56/73 (76.71%) cases. All 30 
controls showed negative results. RLEP PCR technique had a significantly greater 
positivity (especially in early stages of leprosy) than ZN staining (p< 0.001). 
Suggested algorithm for diagnosis, whenever there is clinical suspicion, we can either 
go for smear for AFB or histology to confirm the diagnosis. A positive smear for AFB is 
confirmatory. If it is negative then, we can subject the specimen for gene probes or 
PCR/In-Situ PCR/RLEP PCR. If the result is positive, it is diagnostic of leprosy.  On 
the other hand, if histology shows characteristic features then it is confirmatory; if it is 
not characteristic, we can go for in-situ hybridization. A positive in-situ hybridization is 
diagnostic of leprosy; if it is negative then we can opt for in-situ PCR. 
To conclude, leprosy often poses a diagnostic dilemma. It is important that after a good 
clinical assessment, new diagnostic tests be used to diagnose the condition at an early 
stage & prevent complications/ deformities. 
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INTRODUCTION
Leprosy is an ancient disease, 
earliest described in Asia (India & China) 
around 6th century B.C. It was described 
as Kustha-Roga (in Sanskrit it means 
eating away) by Susruth Samhita (600 
B.C) (1).  In 1873 Dr. Gerhard Henrik 
Armaeur Hansen  of Norway discovered 
M. leprae as the causative agent of leprosy 
(2).
Etiology : 
M. leprae  i s  an  ob l iga te  
intracellular bacillus (0.3–1 m wide and 
1–8 m long) that is confined to humans 
and armadillos.  The organism is acid-fast, 
indistinguishable microscopically from 
other mycobacteria, and ideally detected 
in tissue sections by a modified Fite stain. 
The bacilli has an  extremely slow 
dividing time  (once every 2 weeks); the 
incubation period ranges from 6 months to 
more than 40 years and averages  from2 to 
5 years (3).
Epidemiology :  
Leprosy is almost exclusively a 
disease of the developing world, affecting 
areas of Asia, Africa, Latin America, and 
the Pacific. While Africa has the highest 
disease prevalence, Asia has the most 
cases. More than 80% of the world's cases 
occur in a few countries: India, China, 
Myanmar, Indonesia, Brazil, Nigeria, 
Madagascar, and Nepal. Countrywise, 
maximum number of cases of leprosy 
reside in India (4) (Table 1).
     Table 1 : Trends in the detection of new cases of leprosy, 
by WHO Region, 2008–2011
WHO Region No. of new cases detected 
2008 2009  2010  2011  
Global 249007 244796  228474  219 075
India 134184 133717  126800 127 295
Table 2 : Leprosy situation in India first quarter 2012 (WHO)
Registered
Prevalence
No. of
new cases
 
detected
 
(2011)
 
No. of
new cases
 
of MB
 
leprosy
 
No. of
females
 
among
 
new cases
 
No. of
new cases
 
among
 
children–
 
No. of new
cases with
 
grade-2
 
disabilities
 
No. of
relapses
 
(2011)
 
Cure rate (%)
PB MB
83 187 127 295
 
63 562
 
47 111
 
12 305
 
3 834
 
690
 
95.28 90.56
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Clinical Manifestations :
The cardinal features of leprosy 
are a skin patch with sensory loss, nerve 
enlargement, and acid-fast bacilli in the 
skin (5). The clinical features are 
summarized in Table 3.
Table 3 : Clinical Classification of Leprosy (1)
Features TT BT BB BL LL
Number of 
lesions
Single usually
 
Single or few
 
Several
 
Many
 
Very many
Site of 
lesions
Variable
 
Variable
 
Variable
 
Variable 
 
Small
Surface of 
lesions
Very dry, 
sometimes 
scaly
 
Dry
 
Slightly 
 
Shiny
 
Shiny
Sensations in 
lesions
Absent
 
Markedly 
diminished 
Moderately 
diminished  
slightly
 
diminished  
Not affected
Hair growth Absent Markedly 
diminished 
Moderately 
diminished  
Moderately 
diminished  
Not affected
AFB in 
lesions
Nil
 
Nil or scanty
 
Moderate 
number
 
Many
 
Very 
many(plus
globi)
AFB in nasal 
scrapping /in 
nose blows
 
Nil
 
Nil
 
Nil
 
Usually nil
 
Very 
many(plus 
globi)
Lepromin 
test
Strongly 
positive(+++)
Weakly 
positive(+ or 
++)
Negative
 
Negative
 
Negative
 After inoculation of M.Leprae, 
there will be either no disease with 
complete resistance or there will be 
clinical disease developing through 
indeterminate leprosy.  Indeterminate 
leprosy, is an early form of the disease that 
features only a small number of skin 
lesions and no nerve involvement. It is a 
very early form of leprosy and may either 
be cured or progress to one of the other 
forms of leprosy depending on their 
immune status (6, 7). Within each type of 
leprosy, patient may remain in that stage, 
improve to a less debilitating form or 
worsen to a more debilitating form 
depending on their immune state. The 
polar forms of leprosy, tuberculoid 
leprosy and lepromatous leprosy, are 
immunologically stable, whereas the 
intermediate forms, including borderline 
tuberculoid leprosy, borderline leprosy, 
and borderline lepromatous leprosy, are 
immunologically unstable and lead to 
either a gradual decline toward the 
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lepromatous pole or upgrading 'reversal 
reactions' toward the tuberculoid pole (8).
 T u b e r c u l o i d  l e p r o s y  i s  
characterized by a vigorous cellular 
immune response and limited humoral 
immune responses to M. leprae, usually 
involving the skin and nerves and 
resulting in few skin lesions. Lepromatous 
leprosy, on the other hand, is characterized 
by a minimal cellular immune response 
and a vigorous humoral immune response 
and, consequently, extensive skin 
involvement.
 Patients with overt disease form 
just the tip of iceberg.  It is extremely 
important to identify the at risk population 
in the community to bring down the 
disease burden.
Diagnosis of Leprosy :
Clinical diagnosis :
It is diagnosed by the presence of at least 
two of the following three cardinal signs 
or the last one independently (5): 
(i) Loss/impairment of cutaneous 
sensation,
(ii) Thickened nerves,
(iii)  Presence of AFB.
Slit skin Smear for AFB procedure:
 Demonstration of M.Leprae in slit 
skin smears by Z-N staining method is 
considered as confirmatory.
Histopathology: 
 T h e  h i s t o p a t h o l o g i c a l  
examination of skin biopsy can help in 
confirming the diagnosis, classification of 
the disease and assessment of bacterial 
load. In early stage of the disease the 
diagnostic value of histopathology is 
limited. The earliest histological response 
appears in the form of a lymphocytic 
infiltrate, a non- specific feature, which 
heralds the onset of almost all chronic 
dermatoses. A definitive histological 
diagnosis of leprosy at this early stage 
requires:
(a)  The presence of infiltration within 
dermal nerves, and 
(b)  The presence of Acid Fast Bacilli 
(AFB).
 These defining features are, 
however, not always seen early in the 
evolution of the disease, and confirmation 
of diagnosis is often not possible. To add 
to this, in the pediatric age group it is 
difficult to elicit impairment of cutaneous 
sensation and finding of thickened nerves. 
Majority of cases in children are 
paucibacillary and demonstration of AFB 
is very low, making the diagnosis of 
leprosy even more difficult (9).
 With this background, we 
conducted many studies in our department 
to find out tests for  early and quick 
identification of leprosy in children. A 
brief overview of those studies is as 
follows:-
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1.  Fluorescent leprosy antibody 
absorption test (FLA-ABS):
 This technique is highly sensitive 
in detecting the antibodies against M. 
Leprae antigen by immune fluorescent 
technique and is useful in identifying 
healthy contacts of patients who are at risk 
of developing disease (10) (Table 4).
  We conducted a study of healthy 
children who were close contacts of 
leprosy patients and followed them for 5 
years (from1986-1990) (11) in order to:
1. Detect subclinical infection and 
observe the development of overt 
disease by using the Fluorescent 
Leprosy Antibody Absorption 
Test (FLA-ABS) and the lepromin 
test which assesses the humoral 
and cell-mediated immunity 
(CM1), respectively;
2. Evaluate the efficacy of dapsone 
as a chemoprophylactic agent in 
the 'at risk' contacts.
 455 healthy contacts were studied. 
Majority of the contacts of multibacillary 
patients (303) were FLA-ABS positive 
(75 per cent) and lepromin negative (55 
per cent) showing that although most of 
them had been infected, the lepromin 
status was negative (P < 0.01). On the 
other hand, the majority of the contacts of 
paucibacillary patients (152) were 
lepromin positive (57 per cent) (P<0.05) 
indicating a good cell mediated immune 
response. Furthermore, only 61 per cent of 
contacts of paucibacillary patients were 
FLA-ABS positive as compared to 
75percent of contacts of multibacillary 
patients demonstrating that the former had 
been exposed to a lesser quantum of 
infection (P<0.05).On the basis of results 
of FLA-ABS and lepromin tests, these 
455 contacts were classified into four 
groups, viz. Group I comprising children 
who were FLA-ABS positive and 
lepromin positive; Group II, who were 
FLA-ASS positive and lepromin 
negative; Group III, who were FLA-ABS 
negative and lepromin positive; and 
Group IV who were FLA-ABS negative 
and lepromin negative. During the follow- 
up period of 5 years, only two out of 155 
children in Group I developed the disease 
showing that their good CMI had been 
able to contain the disease. Out of 166 
contacts in Group II, 18 developed the 
disease mainly of the tuberculoid type. 
Most of these children were contacts of 
multibacillary patients. None of the 
children in Groups III and IV developed 
the disease. These findings were 
statistically significant (P <0.01) (Table 4, 
5).
 Out of the 166 children in Group II 
(the 'at risk' group), 70 were treated as 
controls while 96 were put on prophylaxis 
with dapsone which was continued for 3 
years after the contact with the source 
patient had ceased, or for 3 years after the 
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source patient became non-infective. The 
incidence of disease was significantly 
lower among children who received 
chemoprophylaxis (P<0.05). 
 Our study demonstrates the value 
of the FLA-ABS and lepromin tests in 
detecting sub-clinical infection and for 
identifying the 'at risk' contacts of leprosy 
patients in the community. It clearly 
establishes the chemoprophylactic value 
of dapsone for the 'at risk' contacts, 
particularly for those in the 'high risk' 
ca t egory.  In  pur suance  o f  ou r  
Government's policies under the National 
Leprosy Eradication programme, this 
study suggests the need to carry out 
surveillance surveys in the endemic 
population to identify, follow, and offer 
chemoprophylaxis to those at risk (12).
Table 4 : Development of Disease in contacts during 5 years follow-up
GROUPS STATUS
 
NO. OF CONTACTS
 
INCID -
ENCE 
(%)
 
 
RELA -
TIVE 
RISK
 
FLA -
ABS
 
 
LEPR -
OMIN
 
 
TOTAL
 
 
DEVELOP 
DISEASE
 
 
I
II
(AT RISK) 
III
IV
+
 
 
+
 
 
 
 
 
 
 -
 -
 
+
 
 
-
 
 
 
 
 
 
 +
 -
 
155
 
2
 
 
12
 
1.29
 
 
17.14
 
 
1:77.51  
1:9.2
 
 
 
 
 
 -
 -
 
 
166
 
 
 
 
 
 
 68
 66
 
 
70 (CONT.)
 
96 (DDS.P.)  6  6.25  
 
 
 
 -
 -
 
  
 
 
 -
 -
 
TOTAL 455 20 4.4 1:22.75
STATISTICAL       GROUP II Vs I : z=3.705, p<0.01 
SIGNIFICANCE     GROUP II Vs III: z=4.493, p<0.01
 
GROUP II Vs IV: z=4.493, p<0.01
 
AT RISK CONTACTS          
HIGH RISK GROUP LOW RISK GROUP
 
< 5 YEARS AGE                                     >5 YEARS AGE
 
MALES                                                 FEMALE
l BACT. +VE PATIENTS                            BACT –VE PATIENTS
l
l
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Table 5 : Effect of Chemoprophylaxis in 'At Risk' Contacts
GROUPS CONTROL 
GROUP
D.D.S. GROUP EFFICACY 
RATE (%)
P 
VALUE
CONT -
ACTS
 
 
INCID -
ENCE 
(%)
 
 
CONT -
ACTS
 
  
INCID -
ENCE 
(%)
 
 
HIGH 
RISK
      
< 5 YRS.
 
25
 
 
 
8 
(32.00)
 
 
60
 
 1 
(1.67)
 
 
94.78
 
 <0.01  
MALES
 
30
 
 
8 
(26.67) 
 
45
 
 
2 
(4.44)  
 
83.35
 
 
<0.05
 
BACT. 
+VE
32 
 
9 
(28.13)
 
 
49 
 
2 
(4.08)
 
 
85.50  
 
<0.05
 
LOW 
RISK       
> 5 YRS.
 
45
 
 
4 
(8.89)
 
 
36
 
 
5 
(13.88)
 
 
NIL
 
 
>0.05
 FEMALES
 
40
 
 
4 
(10.00)
 
 
51
 
 
4 
(7.84)
 
 
21.60
 
 
>0.05
 
BACT. –
VE
38 3 
(7.89)
47 4 
(8.51)
NI L >0.05
2.  Gene Probes : 
DNA targeting probes :
Synthetic oligonucleotides are 
used as probes. A number of such probes 
are now available for the detection and 
identification of M. leprae gene 
sequences. 
DNA targeting probes :
They have not been found to be 
useful for identifying active disease both 
because of their poor sensitivity in PB 
cases and also because of persistence of 
signals for quite some time after bacterial 
death.
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RNA targeting probes:
Targeting of RNA has special 
importance. RNA is a much more unstable 
molecule than DNA. As RNA degrades 
faster after death, their demonstration or 
quantification is likely to correlate better 
with the presence of live bacteria in the 
lesions. rRNA has become a popular target 
choice for probe development, because of 
evolutionary conserved as well as variable 
stretches in rRNA gene region, presence 
of large copy number and better 
correlation with viability. A number of 
rRNA targeting probe for detection of 
M.leprae have been developed. These 
probes have been observed to be sensitive 
enough to detect up to 100 - 1000 live cells 
directly without amplification. Further 
assays for quantitative measurement of 
these signals have been developed. These 
probes have been found to be useful for 
confirming active disease, monitoring the 
course of treatment and also diagnosing a 
relapse (13). This strategy of targeting 
rRNA has been observed to 10-100 folds 
more sensitive than DNA detection in 
biopsy specimens from leprosy cases. 
These probes appear to have potential role 
in diagnosis of MB relapse and also some 
of the PB leprosy relapses. These rRNA 
probes has been used by in-situ 
hybridization to demonstrate M. leprae 
specific RNA for this signifies the 
presence of active infection.
We conducted  this study from 
1992-94 (14) on 651 patients & 40  
controls .Children less than 16 yrs age 
group were selected. History, clinical & 
smear exam was done in all cases. 
Majority of cases were of borderline 
tuberculoid type 291/651.  As the age 
increased the skin lesions also increased. 
Majority of patients had macular 
hypopigmented les ions/ impaired  
sensation, with nerve thickening. Nerve 
thickening was seen in 301 cases, BT = 
44.7% cases; BB= 23.5% cases. Lepromin 
test, skin biopsy, gene probe studies were 
done in 100 patients & all controls.75/100 
cases were positive in probe 1 & 61/100 
cases were positive in probe 2.We also  
studied a correlation of histopathology 
with probe test (Table 6 & 7).
Results of gene probes :
A total of 87 cases were positive 
by gene probes (P < 0.05).57 cases were 
detected by both the probes, 22 additional 
cases were detected by P1 only and 8 
additional cases were detected by p2 only. 
13 cases were left undetected which may 
be due to decreased bacterial load or 
inadequate sample. From the above 
results it is clear that p1 was better than p2. 
All smear +ve cases, lepromin +ve cases 
and majority of smear –ve cases were 
detected by this method. 9 cases (4 
indeterminate & 5 nonspecific) with 
inconclusive histopathology were also  
detected by this method (Table 8).
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Table 6 : Age & Sex Distribution
Age
(Yrs.)
Type of Disease
Total
I TT BT BB BL LL
0-5 9 9 - 9  -  - 27
6-10 - 9 99 27  9 - 144
11 -16 54 9 192  117 81 27  480
Total 63 27 291 153 90 27 651
2
X  = 6.308, df = 4, P < 0.05, Male = 522, Female = 129
Table 7 : Correlation : Smear status with Probe Tests
SMEAR 
STATUS
 NO. OF 
CASES 
PROBE 1 PROBE 2
+                            -
 
+                    -
POSITIVE
 
38
 
35
 
3
 
30
 
8
 
NEGATIVE 62 40 22  31  31  
TOTAL 100 75 25 61 39
2 2
P :X  = 9.564, df = 1, p < 0.05, P :X  = 8.299, df = 1, p<0.05
1 2
Table 8 : Correlation : Histopathology with Probe Tests
TYPE OF 
DISEASE
 
NO. OF 
CASES
 
 
 
PROBE 1   
 
PROBE 2   
+ 
 
 +
 
 -
 
 +
 
 +
 
 -
 
I 4
 
3
 
-
 
1
 
1
 
-
 
3
 
TT 2 2 -  -  2  -  -  
BT 6 3 3  -  3  -  3  
BB 4
 
2
 
-
 
2
 
2
 
-
 
2
 
BL 6
 
6
 
-
 
-
 
-
 
2
 
4
 
LL 3
 
3
 
-
 
-
 
3
 
-
 
-
 NON SPEC
 
5
 
5
 
-
 
-
 
5
 
-
  
Total 30 24 4 3 16 2 12
2 2
P :X =34.667, df=12, p<0.01; P :X =33.497, df=12, p<0.01
1 2
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3.  Enzyme -linked immunosorbent 
assay (ELISA) :
We assessed the antibody response 
against 35 kDa antigen by Serum Antibody 
Competition Test (SACT).  Nearly 50% 
smear negative cases, 42% Lepromin 
positive cases & 70% Lepromin negative 
cases showed positive antibody response. 
No control had a positive response.
4.  In-situ Hybridization : 
In-situ hybridization uses a labeled 
complementary DNA/RNA strand to 
localize specific DNA/RNA in a portion of 
section of tissue. In-situ hybridization 
significantly enhances the diagnosis in 
early cases (15).
We evaluated a correlation of 
clinical, histopathological, in-situ 
hybridization and PCR features on 22 
patients in 2007.  Skin smears for AFB 
were positive in 2/22 cases, histopathology 
confirmed diagnosis in 6/22 cases and non-
specific histopathology was observed in 
16/22 cases. In-situ hybridization was 
positive in 10/ 22 cases (Table 9).
PCR was done in 15 cases and was 
positive in 10/15 cases. Out of these 15 
cases, 1 child had a positive smear; 
histopathology was positive in only 4 cases 
(Table 10).
Thus,  PCR and  IN SITU 
HYBRIDISATION significantly improved 
the diagnostic yield in early cases and in 
those with non specific histopathology.
 In-situ hybridization offers 
excellent structural correlation and permits 
the concomitant study of tissue pathology. 
However, this method needs further 
evaluation on a larger sample size. 
Therefore, we can conclude that till the 
potential of in-situ hybridization to 
diagnose leprosy is fully explored, PCR 
can be used as a diagnostic method in cases 
of early leprosy where clinical diagnosis is 
doubtful and histopathology is nonspecific.
Table 9 : Correlation of Clinical Histopathological, In-situ Hybridization and 
PCR features of cases
Clinical 
type
No. 
tested
 
 
Skin 
Smear 
for AFB
 
 
Histopath. 
Dx 
confirmed  
Histopath. 
Dx 
nonspecific  
In -situ 
hybridization
 
 
PCR
 
+ve
 
-ve
 
+ve
 
-ve
 
+ve -ve
I 1 0 1 1 0  1  0  0/1 1/1
BT 6 0 6 2 4  2  4   
BB 10
 
0
 
10
 
1
 
9
 
3
 
7
 
6/9 3/9
BL 5
 
2
 
3
 
2
 
3
 
4
 
1
 
1/1 0/9
Total 22 2 20 6 16 10 12 10/15 5/15
Comparison : Skin smear & in-situ hybridization - p value < 0.05, z value = 3.269
Comparison : Skin smear & PCR – p value < 0.05, z value = 2.967
Comparison : PCR & Histopathology  - p value < 0.05, z value = 4.236
Comparison : PCR & in-situ hybridization - p value > 0.05, z value = 1.960
3/4 1/4
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Table  10 : Correlation of Clinical, Histopathological and PCR Features
Clinical types No tested Positive skin 
smear for 
AFB
 
Confirmatory 
histopathological 
diagnosis
 
Positive PCR 
signals
I 1 0 1  0  
BT 4 0 1  3  
BB 9
 
0
 
1
 
6
 
BL 1
 
1
 
1
 
1
 TOTAL 15 1 4 10
Comparison of skin smear with PCR (1/15 vs 10/15) p value <0.05,z = 3.410.
Comparison of histopathology with PCR (4/15 vs 10/15) p value 
<0.05, z = 2.196.
5. In-situ PCR : 
   
In-situ PCR, also called slide 
PCR, is a method to run PCR directly on 
small tissue samples, tissue microarrays 
(TMA), or other small cell samples, rather 
than extracting DNA or RNA first and 
then performing PCR, RTPCR, or q PCR 
from the extracted material.
In this pioneer work, conducted in 
our department in 2004, we evaluated a 
correlation of clinical  f indings,  
histopathological features  and in-situ 
PCR on 20 patients. Skin smear for AFB 
was positive in 2/20 cases (10%), 
histopathology for AFB was positive in 
9 /20  (45%)  cases .  Nonspec i f ic  
histopathology was observed 11/20 
(77.7%) cases. In situ PCR was positive in 
12/20 (60%) (Table 11).
Results of in situ PCR with nonspecific 
histopathology :
His topa tho logy  d iagnosed  
9/20(45%) cases. In situ PCR done in 
patients with non specific histopathology 
was positive in 4/11 (36.3%). Cases 
conf i rmed by  in-s i tu  PCR and 
histopathology was 13/20(65%). 
Histopathology confirmed the clinical 
diagnosis in 45% of total cases. In situ 
PCR confirmed the diagnosis in 60% of 
total cases, thus enhancing the diagnostic 
yield (16) (Table 12).
Keeping in mind that In-situ PCR 
offer excellent structural correlation 
permitting concomitant study of tissue 
pathology & contamination by foreign 
DNA/RNA does not exist, it is a valuable 
tool for diagnosis of childhood leprosy. 
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Table 11 : Correlation of Clinical, Histopathological
 and in-situ PCR features of Cases
Clini -
cal 
Type
No. 
 
 Skin Smear 
for AFB
 
 
+                _  
Histopath. Dx 
+ve 
 
 
AFB+                
Histopath 
Dx 
 
 
non -sp
 
 
In -situ
  
PCR 
+       _
I 3 0 3 1 0  2  2  1  
BT 4 0 4 2 1  1  2  2  
BB 9 0 9 2 1  6  4  5  
BL 4
 
2
 
2
 
2
 
0
 
2
 
4
 
0
 
Total 20
 
2
 (10%)
18
 (90%)
9(45%)
 
2
 (10%)
11 
(77.7%)
12
 (60%)
8(40%)
Comparison : Skin smear with histopathology : Z = 2.694,    p<0.05
Comparison : Skin smear with in-situ PCR : Z = 3.91, p<0.05
Table 12 : Results of in-situ PCR in cases with nonspecific histopathology
Clini -
cal 
Type
No. 
 
Histopath. Dx 
+ve 
 
 
+             _            
In -situ PCR in 
cases with 
nonspecific 
histopathology
 
+               _
 
Cases confirmed 
by histopath. + 
in-situ PCR 
I 3
 
1
 
2
 
1
 
1
 
2
 
BT 4 3 1 0 1  3  
BB 9 3 6 1 5  4  
BL 4 2 2 2 0  4  
Total 20
 
9/20
 
11/20
  
4/11
 
7/11
 
13/20
 
Percen -
tage 
(100%)
 
(45%)
 
(55%)
 
(36.3%)
 
(63.6%)
 
(65%)
 
Controls 
All 20 samples were negative 
 
2
X  :20.810, P < 0.001, df: 1 
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6.  RLEP PCR :
RLEP PCR detects nucleic acid 
sequence specific to the pathogen & can 
be used for definitive diagnosis of leprosy.  
Due to large size, amplicons of most of the 
PCR based methods like 65kDa, 18kDa, 
36kDa undergo damage/fragmentation 
during the procedure. This does not occur 
with RLEP PCR. Donoghue et al found 
RLEP primer to be 1000 fold more 
sensitive than 36kDa primers. Higher 
sensitivity of RLEP PCR than slit skin 
smear for AFB is due to repetition of 
RLEP sequence 28 times in M. leprae 
chromosome.  RLEP based PCR on skin 
smears can be a useful tool to confirm 
early cases of leprosy, where skin smears 
are negative and skin biopsy is not 
feasible. Very few studies are available in 
the world literature on the diagnostic 
value of RLEP PCR in childhood leprosy.
                                       
With  th is  background we 
conducted this study from 2007 to 2008 & 
2010- 2012. 73 cases of either sex, < 18 
years of age, with hypopigmented 
/ e ry thema tous  l e s ions  showing  
partial/total loss of sensation and/or 
presence of thickened nerves were 
studied. 30 healthy children were taken as 
controls. After clinical examination & 
categorization (TT, BT, BB, BL, LL) two 
skin smears were taken, one for Z-N 
staining for AFB & another for RLEP 
PCR.  Af te r  DNA ext rac t ion  & 
amplification, electrophoresis was done & 
presence of 129bp fragments was 
considered as positive result. Z-N staining 
for AFB was positive in 17/73 (23.28%) 
cases and RLEP PCR in 56/73 (76.71%) 
cases. All controls showed negative 
results. RLEP PCR technique had a 
significantly greater positivity (especially 
early stages) than ZN staining (p< 0.001) 
(Table 13).
Thus, RLEP PCR on skin smears 
can be a useful tool to confirm early cases 
of leprosy, where skin smears are negative 
and skin biopsy is not feasible.
Table 13 : Correlation: skin smear for AFB vs. RLEP based PCR
Clinical Type
 
No. of cases
 
Smear positive
 
RLEP  PCR positive 
T 3
 
NIL
 
1
 
BT 27
 
NIL
 
21
 
BB 31 10 25  
BL 11 6 8  
LL 1 1 1  
Total 73
 
17
 
56
 
% 100 23.28% 76.71%
2
X -39.570        ; P < 0.001          D.F. =1
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Suggested Algorithm : 
On the basis of our 20 years 
experience with leprosy patients, we 
propose the following algorithm for 
diagnosis.
Whenever there is clinical 
suspicion, we can either go for smear for 
AFB or histology to confirm the 
diagnosis. A positive smear for AFB is 
confirmatory. If it is negative then, we can 
subject the specimen for gene probes or 
PCR/In-Situ PCR/RLEP PCR. If the result 
is positive, it is diagnostic of leprosy. On 
the other hand, if histology shows 
characteristic features then it is 
confirmatory; if it is not characteristic, we 
can go for in-situ hybridization. A positive 
in-situ hybridization is diagnostic of 
leprosy; if it is negative then we can opt for 
in-situ PCR.
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